Regeneron Pharmaceuticals (REGN)
SG&A Expense Growth
2.22%
Quarterly · Period ending:
REGN SG&A Expense Growth
Latest reported2.22%period ending
Latest reported2.22%period ending
REGN Quarterly SG&A Growth (QoQ) (0.00% → 2.22%)
Latest values, visible window
High-resolution chart · PNG
REGN sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 2.2233% | |
| -16.4258% | |
| 17.817% | |
| 3.7212% | |
| 0.1896% | |
| -20.0959% | |
| 10.8903% | |
| -5.8513% | |
| 10.1306% | |
| -2.1863% | |
| 9.9766% | |
| -1.7638% | |
| 8.4678% | |
| -8.5084% | |
| 24.1731% | |
| 11.0855% | |
| 5.8444% | |
| -19.5854% | |
| 25.7528% | |
| 7.3065% | |
| 2.2436% | |
| 33.6409% | |
| -7.1582% | |
| -6.1441% | |
| -5.1729% | |
| -37.4063% | |
| 92.7727% | |
| 3.3265% | |
| 1.2023% | |
| -40.749% | |
| 33.06% | |
| 1.1916% | |
| 10.3135% | |
| -19.3073% | |
| 33.624% | |
| -0.0463% | |
| 3.3896% | |
| -8.9253% | |
| 20.6973% | |
| -7.5309% | |
| 0.815% | |
| -1.7891% | |
| 40.459% | |
| 20.2792% | |
| 9.81% | |
| 10.6078% | |
| -4.0101% | |
| 46.2183% | |
| -5.9127% | |
| 32.6064% | |
| -15.9025% | |
| 34.6991% | |
| -6.2089% | |
| 33.809% | |
| 23.1555% | |
| -1.7231% | |
| -18.3525% | |
| 60.7417% | |
| 10.4296% | |
| 33.8865% | |
| 5.0147% | |
| 13.4199% | |
| 31.824% | |
| 6.6694% | |
| 4.8126% | |
| -17.7676% | |
| 32.6402% | |
| 10.3851% | |
| -0.3598% | |
| -13.4682% | |
| 18.6752% | |
| -15.5737% | |
| 22.1426% | |
| -3.6279% | |
| 23.1457% | |
| 3.9619% | |
| 8.9368% | |
| 7.5249% | |
| 26.732% | |
| -4.4452% | |
| 5.9368% | |
| -13.7636% | |
| 10.8699% | |
| 0.0483% | |
| 1.139% | |
| 26.6433% | |
| 15.9895% | |
| -1.2043% | |
| 11.7414% | |
| -10.5499% | |
| 17.6618% | |
| 3.2397% | |
| 0.8384% | |
| 2.7935% | |
| 19.7083% | |
| -4.9053% | |
| -13.0588% | |
| 24.451% | |
| 11.0118% | |
| 3.2732% |